Personal information

No personal information available

Activities

Employment (1)

SCRI-LIMCR: Salzburg, AT

2005-01-01 to present | PostDoc (3rd Medical Department)
Employment
Source: Self-asserted source
Franz J Gassner

Works (23)

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group

Cancers
2023-04 | Journal article | Author
Contributors: Bettina Jansko-Gadermeir; Michael Leisch; Franz J Gassner; Nadja Zaborsky; Thomas Dillinger; Sonja Hutter; Angela Risch; Thomas Melchardt; Alexander Egle; Manuel Drost et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Validation of genetic variants from NGS data using Deep Convolutional Neural Networks

2022-04-13 | Preprint
Contributors: Marc Vaisband; Maria Schubert; Franz Josef Gassner; Roland Geisberger; Richard Greil; Nadja Zaborsky; Jan Hasenauer
Source: check_circle
Crossref

Detecting Bacterial–Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia

International Journal of Molecular Sciences
2022-01 | Journal article | Author
Contributors: Ekaterina Akimova; Franz J Gassner; Richard Greil; Nadja Zaborsky; Roland Geisberger
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report

International Journal of Molecular Sciences
2021-08 | Journal article | Author
Contributors: Markus Steiner; Franz J Gassner; Thomas Parigger; Daniel Neureiter; Alexander Egle; Roland Geisberger; Richard Greil; Nadja Zaborsky
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia

International Journal of Molecular Sciences
2021-06 | Journal article | Author
Contributors: Thomas Parigger; Franz J Gassner; Christian Scherhäufl; Aryunni Abu Bakar; Jan Philip Höpner; Alexandra Hödlmoser; Markus Steiner; Kemal Catakovic; Roland Geisberger; Richard Greil et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia

Leukemia
2021-04 | Journal article
Contributors: Franz J. Gassner; Nadja Zaborsky; Ilana Buchumenski; Erez Y. Levanon; Matthias Gatterbauer; Maria Schubert; Stefanie Rauscher; Daniel Hebenstreit; Ferran Nadeu; Elias Campo et al.
Source: check_circle
Crossref

RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia

Cancers
2020-05-05 | Journal article
Contributors: Franz J. Gassner; Nadja Zaborsky; Daniel Feldbacher; Richard Greil; Roland Geisberger
Source: check_circle
Crossref

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.

PloS one
2018-12 | Journal article
Contributors: Schubert M; Hackl H; Gassner FJ; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.

Leukemia
2018-09 | Journal article
Contributors: Zaborsky N; Gassner FJ; Höpner JP; Schubert M; Hebenstreit D; Stark R; Asslaber D; Steiner M; Geisberger R; Greil R et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

Annals of hematology
2018-06 | Journal article
Contributors: Egle A; Steurer M; Melchardt T; Weiss L; Gassner FJ; Zaborsky N; Geisberger R; Catakovic K; Hartmann TN; Pleyer L et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

Annals of hematology
2018-06 | Journal article
Contributors: Egle A; Steurer M; Melchardt T; Weiss L; Gassner FJ; Zaborsky N; Geisberger R; Catakovic K; Hartmann TN; Pleyer L et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Molecular cancer research : MCR
2017-12 | Journal article
Contributors: Gassner FJ; Schubert M; Rebhandl S; Spandl K; Zaborsky N; Catakovic K; Blaimer S; Hebenstreit D; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Oncoimmunology
2017-09 | Journal article
Contributors: Catakovic K; Gassner FJ; Ratswohl C; Zaborsky N; Rebhandl S; Schubert M; Steiner M; Gutjahr JC; Pleyer L; Egle A et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.

Oncotarget
2016-08 | Journal article
Contributors: Zaborsky N; Gassner FJ; Asslaber D; Reinthaler P; Denk U; Flenady S; Hofbauer JP; Danner B; Rebhandl S; Harrer A et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.

British journal of haematology
2015-05 | Journal article
Contributors: Gassner FJ; Zaborsky N; Catakovic K; Rebhandl S; Huemer M; Egle A; Hartmann TN; Hartmann TN; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.

Haematologica
2015-04 | Journal article
Contributors: Zaborsky N; Holler C; Geisberger R; Asslaber D; Gassner FJ; Egger V; Piñón-Hofbauer J; Kocher T; Hartmann TN; Hartmann TN et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.

European journal of immunology
2014-10 | Journal article
Contributors: Huemer M; Rebhandl S; Zaborsky N; Gassner FJ; Hainzl S; Weiss L; Hebenstreit D; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

APOBEC3 signature mutations in chronic lymphocytic leukemia.

Leukemia
2014-05 | Journal article
Contributors: Rebhandl S; Huemer M; Gassner FJ; Zaborsky N; Hebenstreit D; Catakovic K; Grössinger EM; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.

European journal of immunology
2014-04 | Journal article
Contributors: Rebhandl S; Huemer M; Zaborsky N; Gassner FJ; Catakovic K; Felder TK; Greil R; Geisberger R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.

Haematologica
2014-02 | Journal article
Contributors: Gassner FJ; Zaborsky N; Neureiter D; Huemer M; Melchardt T; Egle A; Rebhandl S; Catakovic K; Hartmann TN; Hartmann TN et al.
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Lysine residue at position 22 of the AID protein regulates its class switch activity.

PloS one
2012-02 | Journal article
Contributors: Geisberger R; Huemer M; Gassner FJ; Zaborsky N; Egle A; Greil R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.

Cancer immunology, immunotherapy : CII
2010-09 | Journal article
Contributors: Gassner FJ; Weiss L; Geisberger R; Hofbauer JP; Egle A; Hartmann TN; Hartmann TN; Greil R; Tinhofer I
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.

Journal of immunotherapy (Hagerstown, Md. : 1997)
2009-04 | Journal article
Contributors: Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
Source: Self-asserted source
Franz J Gassner via Europe PubMed Central

Peer review (1 review for 1 publication/grant)

Review activity for Biomolecules. (1)